192 related articles for article (PubMed ID: 18709413)
21. Predictive factors for complete renal tumor ablation using RFA.
Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses.
Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS
AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
24. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
25. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
26. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors.
Breen DJ; Rutherford EE; Stedman B; Roy-Choudhury SH; Cast JE; Hayes MC; Smart CJ
Cardiovasc Intervent Radiol; 2007; 30(5):936-42. PubMed ID: 17573550
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
30. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors.
Javadi S; Ahrar JU; Ninan E; Gupta S; Matin SF; Ahrar K
J Vasc Interv Radiol; 2010 May; 21(5):690-5. PubMed ID: 20227295
[TBL] [Abstract][Full Text] [Related]
31. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
32. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
33. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
[TBL] [Abstract][Full Text] [Related]
34. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.
del Cura JL; Zabala R; Iriarte JI; Unda M
Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208
[TBL] [Abstract][Full Text] [Related]
35. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
36. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience.
Kariniemi J; Ojala R; Hellström P; Sequeiros RB
Acta Radiol; 2010 May; 51(4):467-72. PubMed ID: 20380606
[TBL] [Abstract][Full Text] [Related]
37. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
38. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
39. Imaging-guided radiofrequency ablation of solid renal tumors.
Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
